Global Transplantation Therapeutics Drugs Market Growth (Status and Outlook) 2025-2031

September 2025 | 100 pages | ID: G0151D95F61EN
LP Information

Abstracts

According to this study, the global Transplantation Therapeutics Drugs market size will reach US$ million by 2031.

Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Transplantation Therapeutics Drugs Industry Forecast” looks at past sales and reviews total world Transplantation Therapeutics Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Transplantation Therapeutics Drugs sales for 2025 through 2031. With Transplantation Therapeutics Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transplantation Therapeutics Drugs industry.

This Insight Report provides a comprehensive analysis of the global Transplantation Therapeutics Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transplantation Therapeutics Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transplantation Therapeutics Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transplantation Therapeutics Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transplantation Therapeutics Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Transplantation Therapeutics Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Calcineurin Inhibitors
• Anti-Proliferative Agents
• Corticosteroids
• Others

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• GlaxoSmithKline
• AbbVie
• Pfizer
• Astellas Pharma
• Gilead Sciences
• SBI Biotech
• Sanofi
• Takeda

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transplantation Therapeutics Drugs Market Size (2020-2031)
  2.1.2 Transplantation Therapeutics Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Transplantation Therapeutics Drugs by Country/Region (2020, 2024 & 2031)
2.2 Transplantation Therapeutics Drugs Segment by Type
  2.2.1 Calcineurin Inhibitors
  2.2.2 Anti-Proliferative Agents
  2.2.3 Corticosteroids
  2.2.4 Others
2.3 Transplantation Therapeutics Drugs Market Size by Type
  2.3.1 Transplantation Therapeutics Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Transplantation Therapeutics Drugs Market Size Market Share by Type (2020-2025)
2.4 Transplantation Therapeutics Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Transplantation Therapeutics Drugs Market Size by Application
  2.5.1 Transplantation Therapeutics Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Transplantation Therapeutics Drugs Market Size Market Share by Application (2020-2025)

3 TRANSPLANTATION THERAPEUTICS DRUGS MARKET SIZE BY PLAYER

3.1 Transplantation Therapeutics Drugs Market Size Market Share by Player
  3.1.1 Global Transplantation Therapeutics Drugs Revenue by Player (2020-2025)
  3.1.2 Global Transplantation Therapeutics Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Transplantation Therapeutics Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TRANSPLANTATION THERAPEUTICS DRUGS BY REGION

4.1 Transplantation Therapeutics Drugs Market Size by Region (2020-2025)
4.2 Global Transplantation Therapeutics Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transplantation Therapeutics Drugs Market Size Growth (2020-2025)
4.4 APAC Transplantation Therapeutics Drugs Market Size Growth (2020-2025)
4.5 Europe Transplantation Therapeutics Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Transplantation Therapeutics Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Transplantation Therapeutics Drugs Market Size by Country (2020-2025)
5.2 Americas Transplantation Therapeutics Drugs Market Size by Type (2020-2025)
5.3 Americas Transplantation Therapeutics Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Transplantation Therapeutics Drugs Market Size by Region (2020-2025)
6.2 APAC Transplantation Therapeutics Drugs Market Size by Type (2020-2025)
6.3 APAC Transplantation Therapeutics Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Transplantation Therapeutics Drugs Market Size by Country (2020-2025)
7.2 Europe Transplantation Therapeutics Drugs Market Size by Type (2020-2025)
7.3 Europe Transplantation Therapeutics Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transplantation Therapeutics Drugs by Region (2020-2025)
8.2 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TRANSPLANTATION THERAPEUTICS DRUGS MARKET FORECAST

10.1 Global Transplantation Therapeutics Drugs Forecast by Region (2026-2031)
  10.1.1 Global Transplantation Therapeutics Drugs Forecast by Region (2026-2031)
  10.1.2 Americas Transplantation Therapeutics Drugs Forecast
  10.1.3 APAC Transplantation Therapeutics Drugs Forecast
  10.1.4 Europe Transplantation Therapeutics Drugs Forecast
  10.1.5 Middle East & Africa Transplantation Therapeutics Drugs Forecast
10.2 Americas Transplantation Therapeutics Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market Transplantation Therapeutics Drugs Forecast
  10.2.2 Canada Market Transplantation Therapeutics Drugs Forecast
  10.2.3 Mexico Market Transplantation Therapeutics Drugs Forecast
  10.2.4 Brazil Market Transplantation Therapeutics Drugs Forecast
10.3 APAC Transplantation Therapeutics Drugs Forecast by Region (2026-2031)
  10.3.1 China Transplantation Therapeutics Drugs Market Forecast
  10.3.2 Japan Market Transplantation Therapeutics Drugs Forecast
  10.3.3 Korea Market Transplantation Therapeutics Drugs Forecast
  10.3.4 Southeast Asia Market Transplantation Therapeutics Drugs Forecast
  10.3.5 India Market Transplantation Therapeutics Drugs Forecast
  10.3.6 Australia Market Transplantation Therapeutics Drugs Forecast
10.4 Europe Transplantation Therapeutics Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market Transplantation Therapeutics Drugs Forecast
  10.4.2 France Market Transplantation Therapeutics Drugs Forecast
  10.4.3 UK Market Transplantation Therapeutics Drugs Forecast
  10.4.4 Italy Market Transplantation Therapeutics Drugs Forecast
  10.4.5 Russia Market Transplantation Therapeutics Drugs Forecast
10.5 Middle East & Africa Transplantation Therapeutics Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market Transplantation Therapeutics Drugs Forecast
  10.5.2 South Africa Market Transplantation Therapeutics Drugs Forecast
  10.5.3 Israel Market Transplantation Therapeutics Drugs Forecast
  10.5.4 Turkey Market Transplantation Therapeutics Drugs Forecast
10.6 Global Transplantation Therapeutics Drugs Forecast by Type (2026-2031)
10.7 Global Transplantation Therapeutics Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Transplantation Therapeutics Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Transplantation Therapeutics Drugs Product Offered
  11.1.3 Novartis Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 GlaxoSmithKline
  11.2.1 GlaxoSmithKline Company Information
  11.2.2 GlaxoSmithKline Transplantation Therapeutics Drugs Product Offered
  11.2.3 GlaxoSmithKline Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GlaxoSmithKline Main Business Overview
  11.2.5 GlaxoSmithKline Latest Developments
11.3 AbbVie
  11.3.1 AbbVie Company Information
  11.3.2 AbbVie Transplantation Therapeutics Drugs Product Offered
  11.3.3 AbbVie Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 AbbVie Main Business Overview
  11.3.5 AbbVie Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Transplantation Therapeutics Drugs Product Offered
  11.4.3 Pfizer Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Astellas Pharma
  11.5.1 Astellas Pharma Company Information
  11.5.2 Astellas Pharma Transplantation Therapeutics Drugs Product Offered
  11.5.3 Astellas Pharma Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Astellas Pharma Main Business Overview
  11.5.5 Astellas Pharma Latest Developments
11.6 Gilead Sciences
  11.6.1 Gilead Sciences Company Information
  11.6.2 Gilead Sciences Transplantation Therapeutics Drugs Product Offered
  11.6.3 Gilead Sciences Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Gilead Sciences Main Business Overview
  11.6.5 Gilead Sciences Latest Developments
11.7 SBI Biotech
  11.7.1 SBI Biotech Company Information
  11.7.2 SBI Biotech Transplantation Therapeutics Drugs Product Offered
  11.7.3 SBI Biotech Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 SBI Biotech Main Business Overview
  11.7.5 SBI Biotech Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Transplantation Therapeutics Drugs Product Offered
  11.8.3 Sanofi Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments
11.9 Takeda
  11.9.1 Takeda Company Information
  11.9.2 Takeda Transplantation Therapeutics Drugs Product Offered
  11.9.3 Takeda Transplantation Therapeutics Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Takeda Main Business Overview
  11.9.5 Takeda Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Transplantation Therapeutics Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Transplantation Therapeutics Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Calcineurin Inhibitors
Table 4. Major Players of Anti-Proliferative Agents
Table 5. Major Players of Corticosteroids
Table 6. Major Players of Others
Table 7. Transplantation Therapeutics Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Transplantation Therapeutics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Transplantation Therapeutics Drugs Market Size Market Share by Type (2020-2025)
Table 10. Transplantation Therapeutics Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Transplantation Therapeutics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Transplantation Therapeutics Drugs Market Size Market Share by Application (2020-2025)
Table 13. Global Transplantation Therapeutics Drugs Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Transplantation Therapeutics Drugs Revenue Market Share by Player (2020-2025)
Table 15. Transplantation Therapeutics Drugs Key Players Head office and Products Offered
Table 16. Transplantation Therapeutics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Transplantation Therapeutics Drugs Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Transplantation Therapeutics Drugs Market Size Market Share by Region (2020-2025)
Table 21. Global Transplantation Therapeutics Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Transplantation Therapeutics Drugs Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Transplantation Therapeutics Drugs Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Transplantation Therapeutics Drugs Market Size Market Share by Country (2020-2025)
Table 25. Americas Transplantation Therapeutics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Transplantation Therapeutics Drugs Market Size Market Share by Type (2020-2025)
Table 27. Americas Transplantation Therapeutics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Transplantation Therapeutics Drugs Market Size Market Share by Application (2020-2025)
Table 29. APAC Transplantation Therapeutics Drugs Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Transplantation Therapeutics Drugs Market Size Market Share by Region (2020-2025)
Table 31. APAC Transplantation Therapeutics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Transplantation Therapeutics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Transplantation Therapeutics Drugs Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Transplantation Therapeutics Drugs Market Size Market Share by Country (2020-2025)
Table 35. Europe Transplantation Therapeutics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Transplantation Therapeutics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Transplantation Therapeutics Drugs
Table 41. Key Market Challenges & Risks of Transplantation Therapeutics Drugs
Table 42. Key Industry Trends of Transplantation Therapeutics Drugs
Table 43. Global Transplantation Therapeutics Drugs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Transplantation Therapeutics Drugs Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Transplantation Therapeutics Drugs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Transplantation Therapeutics Drugs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Novartis Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 48. Novartis Transplantation Therapeutics Drugs Product Offered
Table 49. Novartis Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Novartis Main Business
Table 51. Novartis Latest Developments
Table 52. GlaxoSmithKline Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 53. GlaxoSmithKline Transplantation Therapeutics Drugs Product Offered
Table 54. GlaxoSmithKline Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. GlaxoSmithKline Main Business
Table 56. GlaxoSmithKline Latest Developments
Table 57. AbbVie Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 58. AbbVie Transplantation Therapeutics Drugs Product Offered
Table 59. AbbVie Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. AbbVie Main Business
Table 61. AbbVie Latest Developments
Table 62. Pfizer Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 63. Pfizer Transplantation Therapeutics Drugs Product Offered
Table 64. Pfizer Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Pfizer Main Business
Table 66. Pfizer Latest Developments
Table 67. Astellas Pharma Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 68. Astellas Pharma Transplantation Therapeutics Drugs Product Offered
Table 69. Astellas Pharma Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Astellas Pharma Main Business
Table 71. Astellas Pharma Latest Developments
Table 72. Gilead Sciences Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 73. Gilead Sciences Transplantation Therapeutics Drugs Product Offered
Table 74. Gilead Sciences Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Gilead Sciences Main Business
Table 76. Gilead Sciences Latest Developments
Table 77. SBI Biotech Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 78. SBI Biotech Transplantation Therapeutics Drugs Product Offered
Table 79. SBI Biotech Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. SBI Biotech Main Business
Table 81. SBI Biotech Latest Developments
Table 82. Sanofi Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 83. Sanofi Transplantation Therapeutics Drugs Product Offered
Table 84. Sanofi Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Takeda Details, Company Type, Transplantation Therapeutics Drugs Area Served and Its Competitors
Table 88. Takeda Transplantation Therapeutics Drugs Product Offered
Table 89. Takeda Transplantation Therapeutics Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Takeda Main Business
Table 91. Takeda Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Transplantation Therapeutics Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Transplantation Therapeutics Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Transplantation Therapeutics Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Transplantation Therapeutics Drugs Sales Market Share by Country/Region (2024)
Figure 8. Transplantation Therapeutics Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Transplantation Therapeutics Drugs Market Size Market Share by Type in 2024
Figure 10. Transplantation Therapeutics Drugs in Hospital Pharmacies
Figure 11. Global Transplantation Therapeutics Drugs Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Transplantation Therapeutics Drugs in Retail Pharmacies
Figure 13. Global Transplantation Therapeutics Drugs Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Transplantation Therapeutics Drugs in Online Pharmacies
Figure 15. Global Transplantation Therapeutics Drugs Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Transplantation Therapeutics Drugs Market Size Market Share by Application in 2024
Figure 17. Global Transplantation Therapeutics Drugs Revenue Market Share by Player in 2024
Figure 18. Global Transplantation Therapeutics Drugs Market Size Market Share by Region (2020-2025)
Figure 19. Americas Transplantation Therapeutics Drugs Market Size 2020-2025 ($ millions)
Figure 20. APAC Transplantation Therapeutics Drugs Market Size 2020-2025 ($ millions)
Figure 21. Europe Transplantation Therapeutics Drugs Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Transplantation Therapeutics Drugs Market Size 2020-2025 ($ millions)
Figure 23. Americas Transplantation Therapeutics Drugs Value Market Share by Country in 2024
Figure 24. United States Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Transplantation Therapeutics Drugs Market Size Market Share by Region in 2024
Figure 29. APAC Transplantation Therapeutics Drugs Market Size Market Share by Type (2020-2025)
Figure 30. APAC Transplantation Therapeutics Drugs Market Size Market Share by Application (2020-2025)
Figure 31. China Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. India Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Transplantation Therapeutics Drugs Market Size Market Share by Country in 2024
Figure 38. Europe Transplantation Therapeutics Drugs Market Size Market Share by Type (2020-2025)
Figure 39. Europe Transplantation Therapeutics Drugs Market Size Market Share by Application (2020-2025)
Figure 40. Germany Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. France Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Transplantation Therapeutics Drugs Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Transplantation Therapeutics Drugs Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Transplantation Therapeutics Drugs Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Transplantation Therapeutics Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 54. APAC Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 55. Europe Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 57. United States Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 58. Canada Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 59. Mexico Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 60. Brazil Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 61. China Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 62. Japan Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 63. Korea Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 65. India Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 66. Australia Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 67. Germany Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 68. France Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 69. UK Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 70. Italy Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 71. Russia Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 72. Egypt Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 73. South Africa Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 74. Israel Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 75. Turkey Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)
Figure 76. Global Transplantation Therapeutics Drugs Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Transplantation Therapeutics Drugs Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Transplantation Therapeutics Drugs Market Size 2026-2031 ($ millions)